Antibiotics for Myocardial Infarction?: A Possible Role of Infection in Atherogenesis and Acute Coronary Syndromes

Schussheim, A.E.; Fuster, V.
March 1999
Drugs;Mar1999, Vol. 57 Issue 3, p283
Academic Journal
The role of inflammatory mechanisms in the initiation, progression and clinical expression of atherosclerosis is increasingly appreciated. With this awareness, the possibility that acute or chronic infection may initiate or modulate these processes is an active area of investigation. Infectious organisms may influence the atherosclerotic process through direct local effects on the coronary endothelium, on vascular smooth muscle cells and on macrophages in the atherosclerotic lesion. Infection may also exert systemic effects by inducing the elaboration of cytokines, the creation of a hypercoagulable state and by activating monocytes, causing possible transmission of infectious material to atherosclerotic lesions. Macrophages may then elaborate multiple mediators which destabilise plaque, promoting rupture and progression. Seroepidemiological data have identified associations between clinically active atherosclerosis and evidence of infection with Helicobacter pylori, Chlamydia pneumoniae and some herpesviridae. In addition, pathological examinations have demonstrated the presence of infectious organisms in coronary artery plaques. Cytomegalovirus, for example, has been identified pathologically to be associated with transplant vasculopathy and with an increased risk of restenosis following coronary intervention. Finally, recent pilot trials have demonstrated that macrolide antibacterial treatment directed against C. pneumoniae reduces the risk of recurrent coronary events. Infectious organisms may therefore influence atherogenesis through multiple pathways, and pathological and seroepidemiological investigations provide evidence of this association. Future large-scale clinical trials are needed to further evaluate the evidence of causality and the efficacy of antibacterial therapy for coronary artery disease.


Related Articles

  • Enhanced humoral response to H. pylori or/and Chlamydia spp. as a distinctive trait of patients with coronary heart disease (CHD). Chmiela, M.; Wisniewska, M.; Miszczak, A.; Rechcinski, T.; Kowalewicz — Kulbat, M.; Wadstrom, T.; Rudnicka, W. // Gut;Sep2002 Supplement 2, Vol. 51, pA77 

    Seroepidemiological studies risen a hypothesis that an infection can initiate or maintain the atherosclerosis. The levels of antibodies to Helicobacter pylori, Chlamydia spp. and Mycobacterium bovis BCG were determined in the sera from the patients with coronary heart disease (CDH), H. pylori...

  • Editorial preface to the first issue of 2012. Hongqiang Cheng // Journal of Cardiovascular Disease Research (Medknow Publications;Jan-Mar2012, Vol. 3 Issue 1, p1 

    An introduction is presented in which the editor discusses various reports within the issue on topics including anti-atherosclerotic activities of anti-diabetic drugs, hypertrophic cardiomyopathy, and the prevalence of helicobacter pylori infection.

  • Chronic Helicobacter pylori infection is associated with peripheral arterial disease. Yasunori Sawayama; Maki Hamada; Shigeru Otaguro; Shinji Maeda; Hachiro Ohnishi; Yayoi Fujimoto; Yuji Taira; Jun Hayashi // Journal of Infection & Chemotherapy (Springer Science & Business;Jun2008, Vol. 14 Issue 3, p250 

    Abstract  It is reported that Helicobacter pylori infection is associated with coronary atherosclerosis both epidemiologically and pathogenetically, but no conclusions have yet been reached. Therefore, we investigated the relationship between H. pylori infection and peripheral arterial...

  • Don't be too quick to treat H pylori; wait for ulcer recurrence.  // Modern Medicine;Feb94, Vol. 62 Issue 2, p15 

    Recommends a technique for treating Helicobacter pylori. Triple treatment with bismuth subsalicylate, metronidazole and tetracyline.

  • Gastric juice test for H pylori is quick and simple.  // Modern Medicine;Aug95, Vol. 63 Issue 8, p42 

    Presents an abstract of the study titled `Gastric juice ammonia vs. CLO test for diagnosis of Helicobacter pylori infection,' by D.H. Yang, H.S.Bom, et al, published in the May 1995 issue of `Dig. Dis. Sci.'

  • Breath test will be an important tool to diagnose, treat H pylori infections.  // Modern Medicine;Jul96, Vol. 64 Issue 7, p18 

    Reports that the carbon urea breath test used in detecting the presence of Helicobacter pylori organisms works just as well in a clinical setting as it does in a research setting according to an article by David Y. Graham published in the April 1996 issue of `The American Journal of...

  • Helicobacter Pylori Infection, Immune Response and Vaccination. Lembo, A.; Caradonna, L.; Magrone, T.; Mastronardi, M.L.; Caccavo, D.; Jirillo, E.; Amati, L. // Current Drug Targets - Immune, Endocrine & Metabolic Disorders;Nov2001, Vol. 1 Issue 3, p199 

    It is well known that abnormal immune responses may play a pathogenic role in the H. pylori-related gastropathy. Indeed, as far as humoral immune response is concerned, it is still debated whether specific anti-H. pylori antibodies have a protective or noxious effect in infected hosts. Besides...

  • H pylori rarely recurs following successful triple therapy.  // Geriatrics;Jan94, Vol. 49 Issue 1, p60 

    Rports on a prospective study which showed that the rate of `Helicobacter pylori' reinfection of the Gastro-Intestinal (GI) tract is low after successful treatment with standard triple therapy.

  • Diagnostic test for H pylori.  // Geriatrics;Sep94, Vol. 49 Issue 9, p14 

    States that FlexSure HP is a single-unit test for detecting the presence of IgG antibodies to Helicobacter pylori, a bacterium associated with peptic ulcer disease. Percentage of relative sensitivity and overall agreement; Recommendation for patients with clinical signs and symptoms of GI disease.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics